Cargando…

Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia

Detalles Bibliográficos
Autores principales: Ulhaq, Zulvikar Syambani, Soraya, Gita Vita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351402/
https://www.ncbi.nlm.nih.gov/pubmed/32950258
http://dx.doi.org/10.1016/j.medcli.2020.07.002
_version_ 1783557435551645696
author Ulhaq, Zulvikar Syambani
Soraya, Gita Vita
author_facet Ulhaq, Zulvikar Syambani
Soraya, Gita Vita
author_sort Ulhaq, Zulvikar Syambani
collection PubMed
description
format Online
Article
Text
id pubmed-7351402
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-73514022020-07-13 Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia Ulhaq, Zulvikar Syambani Soraya, Gita Vita Med Clin (Barc) Special Article Elsevier España, S.L.U. 2020-12-24 2020-07-10 /pmc/articles/PMC7351402/ /pubmed/32950258 http://dx.doi.org/10.1016/j.medcli.2020.07.002 Text en © 2020 Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Special Article
Ulhaq, Zulvikar Syambani
Soraya, Gita Vita
Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia
title Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia
title_full Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia
title_fullStr Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia
title_full_unstemmed Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia
title_short Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia
title_sort anti-il-6 receptor antibody treatment for severe covid-19 and the potential implication of il-6 gene polymorphisms in novel coronavirus pneumonia
topic Special Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351402/
https://www.ncbi.nlm.nih.gov/pubmed/32950258
http://dx.doi.org/10.1016/j.medcli.2020.07.002
work_keys_str_mv AT ulhaqzulvikarsyambani antiil6receptorantibodytreatmentforseverecovid19andthepotentialimplicationofil6genepolymorphismsinnovelcoronaviruspneumonia
AT sorayagitavita antiil6receptorantibodytreatmentforseverecovid19andthepotentialimplicationofil6genepolymorphismsinnovelcoronaviruspneumonia